PMID: 8609166Apr 1, 1996Paper

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

The Journal of Cell Biology
L E FrenchJ Tschopp

Abstract

The cell surface receptor Fas (FasR, Apo-1, CD95) and its ligand (FasL) are mediators of apoptosis that have been shown to be implicated in the peripheral deletion of autoimmune cells, activation-induced T cell death, and one of the two major cytolytic pathways mediated by CD8+ cytolytic T cells. To gain further understanding of the Fas system., we have analyzed Fas and FasL expression during mouse development and in adult tissues. In developing mouse embryos, from 16.5 d onwards, Fas mRNA is detectable in distinct cell types of the developing sinus, thymus, lung, and liver, whereas FasL expression is restricted to submaxillary gland epithelial cells and the developing nervous system. Significant Fas and FasL expression were observed in several nonlymphoid cell types during embryogenesis, and generally Fas and FasL expression were not localized to characteristic sites of programmed cell death. In the adult mouse, RNase protection analysis revealed very wide expression of both Fas and FasL. Several tissues, including the thymus, lung, spleen, small intestine, large intestine, seminal vesicle, prostate, and uterus, clearly coexpress the two genes. Most tissues constitutively coexpressing Fas and FasL in the adult mouse are charac...Continue Reading

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Jan 1, 1991·Annual Review of Immunology·P L Cohen, R A Eisenberg
Jan 1, 1991·Annual Review of Neuroscience·R W Oppenheim
Dec 21, 1989·Nature·Y J LiuI C MacLennan
Sep 1, 1989·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·E StathopoulosA L Epstein
Dec 1, 1988·The Journal of Experimental Medicine·B L KotzinL R Herron
Sep 1, 1995·International Immunology·M HahneJ Tschopp
Nov 17, 1995·Science·J W Streilein
Nov 17, 1995·Science·T S GriffithT A Ferguson
Jan 1, 1995·The Journal of Experimental Medicine·M R AldersonD H Lynch
Feb 2, 1995·Nature·J DheinP H Krammer
Mar 10, 1995·Science·S Nagata, P Golstein
Oct 19, 1995·Nature·D BellgrauR C Duke
Aug 26, 1993·Nature·J OgasawaraS Nagata
Mar 10, 1995·Science·H Steller
Feb 1, 1994·Seminars in Immunology·S J RozzoB L Kotzin
Sep 10, 1993·Cell·L A TartagliaD V Goeddel

❮ Previous
Next ❯

Citations

Oct 12, 1999·The Prostate·T E HedlundG J Miller
May 18, 1999·International Journal of Cancer. Journal International Du Cancer·L Peduto EberlL Juillerat-Jeanneret
Feb 7, 2001·International Journal of Cancer. Journal International Du Cancer·M MottoleseF M Venanzi
May 1, 1997·Molecular Reproduction and Development·K SakamakiS Yonehara
Jan 6, 2001·Molecular Reproduction and Development·A L Kierszenbaum
Jul 1, 1998·Clinical Immunology and Immunopathology·P L Arscott, J R Baker
Apr 16, 1998·Springer Seminars in Immunopathology·J AllisonH Yagita
Sep 24, 1999·Immunologic Research·I N Crispe
Jul 18, 2001·Pathology Oncology Research : POR·I Peták, J A Houghton
May 13, 2005·Cancer Immunology, Immunotherapy : CII·Frederik H Igney, Peter H Krammer
May 26, 2010·Cancer Chemotherapy and Pharmacology·Chuan-gang LiWen-sen Wu
Sep 18, 2008·Journal of Assisted Reproduction and Genetics·Wojciech GlabowskiRafal Kurzawa
Jun 14, 2005·Journal of Reproductive Immunology·Mónica ImaraiKevin Maisey
Aug 14, 2013·Tissue & Cell·Hua ZhangSi jiu Yu
Nov 24, 1999·The American Journal of Medicine·P SaikumarM A Venkatachalam
Mar 26, 2003·Experimental Cell Research·Kok Hwee Tan, Walter Hunziker
Sep 24, 1998·Transplantation Proceedings·D MeyerA Thiede
Oct 8, 2003·Gynecologic Oncology·G RajashekharJ M Mongelli
Oct 9, 2002·Human Immunology·Bettina DresskeFred Fändrich
Feb 18, 1999·Toxicology Letters·P H Krammer
Jun 30, 2000·Endocrinology and Metabolism Clinics of North America·E PhelpsJ R Baker
Jan 13, 2000·Current Opinion in Immunology·A V Chervonsky
Feb 19, 2000·Current Opinion in Genetics & Development·M J Pinkoski, D R Green
Feb 19, 2000·Current Opinion in Neurobiology·C RaoulC E Henderson
Aug 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A GemmaS Kudoh
Jul 31, 2002·Seminars in Cancer Biology·Ernst Reichmann
Jun 6, 2003·Cytokine & Growth Factor Reviews·Hae-ock Lee, Thomas A Ferguson
May 1, 1998·Zygote : the Biology of Gametes and Early Embryos·J P XuT Mori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis